N

Nanobiotix SA
D

NBTX

3.35000
USD
-0.01
(-0.30%)
Market Closed
Volume
101
EPS
-1
Div Yield
-
P/E
-4
Market Cap
158,805,856
OverviewSignalsIdeasNews
Related Instruments
    A
    ABCL
    -0.11000
    (-3.99%)
    2.65000 USD
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    A
    ADPT
    -0.51000
    (-9.14%)
    5.07000 USD
    A
    ALLO
    -0.19000
    (-7.71%)
    2.27500 USD
    A
    APLS
    -1.750
    (-6.24%)
    26.280 USD
    A
    ARCT
    -2.310
    (-12.60%)
    16.020 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    I
    IMVT
    -1.440
    (-5.13%)
    26.610 USD
    S
    SGMO
    -0.10000
    (-4.67%)
    2.04000 USD
    More
News

Title: Nanobiotix SA

Sector: Healthcare
Industry: Biotechnology
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.